Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

A reminder to all members that you agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.


984 Pages (Click to Jump) V  « < 980 981 982 983 984 >   
 
  
Reply to this topic

BLT, BENITEC BIOPHARMA LIMITED
theadder
post Posted: Feb 18 2004, 07:40 AM
  Quote Post


Posts: 5,264
Thanks: 1136


[SIZE=1]Serologicals' Research Division, Chemicon International, Inc. and Promega Corporation Enter into an Agreement for DNA-directed RNAi Product Development and Applications


full article at:

http://tinyurl.com/2tp8c

 
colaiscute
post Posted: Jan 29 2004, 03:16 PM
  Quote Post


Posts: 690
Thanks: 4


it would now seem that the rises over the last two days can be attributed to a few insiders buying in expectation of the attached announcement.

all the best...

i still dont hold, but want to soon!


Attached File(s)
Attached File  00413003.pdf ( 71.54K ) Number of downloads: 147

 




--------------------
colaiscute
 
colaiscute
post Posted: Jan 12 2004, 10:17 AM
  Quote Post


Posts: 690
Thanks: 4


IN REPLY TO A POST BY blackbook, Tue 06/01/04 07:05pm   [READ POST]

As a follower and believer in next generation science, I am truely excited by the gene silencing technology BLT is leading in. Simply amazing stuff. To the lay man, its like non destructive genetic engineering.... once mastered, the ability to turn on and off genetic expression in both humans and pathogenic organisms alike.

ALTHOUGH I MAY BE EXCITED BY THE PROMISE OF THIS TECHNOLOGY, I AM SIMPLY UNEXCITED BY THE SHARE PRICE, AND THE SHARE IN GENERAL.

It refuses to break below $1, but its trying, and that is worrying to me. I remember a day, a few days following the CSIRO announcement when there was a 20 cent gap between the bids. Very scary stuff. If this share was better known to the public, and if the public could understand its applications, i would feel price would be back up around 1.30, where i think it belongs.

The problem with next generation science is there isnt much financial interest for the short term.

Short term, id rate BLT as a sell. I dont see enough support, and if price drops below $1, i think it might be hard to get it back up over that, without another positive announcement. Buy in again, when price rises above the $1.20 resistance.

Surely there have to be some people following this share. It may be small, but its hit the papers a few times.

Has a lot of potential, but very risky, IMO

Anyone else out there?



--------------------
colaiscute
 
blackbook
post Posted: Jan 6 2004, 06:35 PM
  Quote Post


Posts: 286
Thanks: 1


Price looks like bottoming. What is the time frame to commercialisation, are we expecting developments soon?

 
andyc
post Posted: Jan 6 2004, 04:26 PM
  Quote Post


Posts: 188


Either that or the traders are moving in for some fun... one to keep a close eye on... I havent got any but will be watching with keen interest...

 
brettan
post Posted: Jan 6 2004, 09:36 AM
  Quote Post


Posts: 244
Thanks: 1


Activity today suggest some form of an Ann is pending

 

Featured Stock Stories





brettan
post Posted: Jan 2 2004, 12:47 PM
  Quote Post


Posts: 244
Thanks: 1


Thanks blackbook

 
blackbook
post Posted: Jan 2 2004, 12:44 PM
  Quote Post


Posts: 286
Thanks: 1


There has been alot of upside removed due to BLT losing "non-human" applications. The human applications will take much much longer to develop and test where as non-human applications are more widespread and quicker to commercialise. A big hit to the company but still a huge upside if they get a few applications off the ground. Certainly one to keep on the watchlist.

 
brettan
post Posted: Jan 2 2004, 10:14 AM
  Quote Post


Posts: 244
Thanks: 1


Does anyone know whay the SP has dropped nearly 30% in last four trading days?

 
colaiscute
post Posted: Dec 23 2003, 11:34 AM
  Quote Post


Posts: 690
Thanks: 4


I am still asking what the fine details of the deal are. I personally dont feel the announcement explains exactly how a compromise has been met. I am a little unsure how significantly BLT will benifit from this compromise.

QUOTE
This agreement fully resolves the dispute between Benitec, CSIRO and Queensland DPI. All
parties retain research rights in their fields of interest. John McKinley, Chairman and Chief
Executive Officer of Benitec said "This deal provides clear and certain commercialisation
pathways for this technology."
Benitec will focus on commercialising ddRNAi for "human applications" including research
models used in functional genomics. CSIRO will focus on commercialising "non-human
applications", including plants, animals and insects. Queensland DPI will continue its ddRNAi
research and will benefit from access to both Benitec and CSIRO's global commercialisation
pathways.


QUOTE
Benitec and CSIRO will share revenues generated from the commercial applications of ddRNAi,
each party retaining the majority of revenue generated from its respective area.


The majority is a good thing, since I believe human applications has a greater potential than non human.



--------------------
colaiscute
 
 


984 Pages (Click to Jump) V  « < 980 981 982 983 984 >

Back To Top Of Page
Reply to this topic


You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.


TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING